Market Cap (In SEK)
407.79 Million
Revenue (In SEK)
50.9 Million
Net Income (In SEK)
-49.72 Million
Avg. Volume
130.42 Thousand
- Currency
- SEK
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 1.57-4.1
- PE
- -
- EPS
- -
- Beta Value
- 0.041
- ISIN
- SE0003943620
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Claus Egstrand
- Employee Count
- -
- Website
- https://www.enzymatica.se
- Ipo Date
- 2011-06-14
- Details
- Enzymatica AB, a life science company, develops and sells medical devices for infection-related diseases. The company's product includes ColdZyme mouth spray, which prevents common cold and reduces the duration of illness. It also provides enzyme formulations. The company sells mouth spray under the ViruProtect brand in Denmark; STADAProtect brand in Germany; Psysiomer Stop Virus brand in France; and Zerinol Virus Defense brand in Italy. Enzymatica AB was incorporated in 2007 and is headquartered in Lund, Sweden.
More Stocks
-
ACONAclarion, Inc.
ACON
-
KEIL
-
PNRPantoro Limited
PNR
-
ACARIXAcarix AB (publ)
ACARIX
-
PRIMEPRO
-
SUKHJITS
-
MCFT
-
BSX